Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Mikolasch (London, United Kingdom), M. Ruparel* (London, United Kingdom), J. Dickson (London, United Kingdom), C. Horst (London, United Kingdom), S. Tisi (London, United Kingdom), S. Quaife (London, United Kingdom), N. Navani (London, United Kingdom), M. Taylor (London, United Kingdom), A. Ahmed (London, United Kingdom), P. Shaw (London, United Kingdom), S. Burke (London, United Kingdom), M. Soo (London, United Kingdom), A. Bhowmik (London, United Kingdom), J. Porter (London, United Kingdom), S. Janes (London, United Kingdom). Interstital lung disease rates and risk factors in a UK lung cancer screening trial. 2208

Member's Comments

No comment yet.

Related content which might interest you: Prior lung disease and risk of lung cancer in women Source: Eur Respir J 2005; 26: Suppl. 49, 598s Year: 2005 Risk factors for early mortality in lung cancer Source: Annual Congress 2012 - Epidemiology and care research of lung cancer Year: 2012 Risk factors for lung cancer worldwide Source: Eur Respir J 2016; 48: 889-902 Year: 2016 Risk factors for lung cancer in COPD Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 Incidence of interstitial lung disease (ILD) and risk factors for developing ILD: A final analysis of a large-scale erlotinib Japanese surveillance study in non-small-cell lung cancer (NSCLC) Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Predictors of major serious manifestations in the terminal stage of lung cancer Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005 Prevalence and characterization of interstitial lung disease in a lung cancer screening program Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009 Prevalence of and risk factors for pulmonary complications after lung cancer surgery in elderly patients with preserved lung function Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018 Evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring? Source: Breathe, 16 (4) 200204; 10.1183/20734735.0204-2020 Year: 2020 Prevalence and burden of bronchiectasis in a lung cancer screening program Source: International Congress 2019 – Airway infection in COPD Year: 2019 Characteristics, incidence, risk factors, and practical management of pneumonitis associated with anti-PD-1 immunotherapy in patients with non-small cell lung cancer Source: International Congress 2019 – Treatment of lung cancer Year: 2019 Evaluation of causes and characteristics of lung cancer mortality Source: Eur Respir J 2005; 26: Suppl. 49, 321s Year: 2005 A case-control study of environmental risk factors of lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 425s Year: 2007 Risk factors and prognosis of non-solid nodules in a lung cancer screening program Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer Year: 2019 Interstitial lung diseases in a lung cancer screening trial Source: Eur Respir J 2011; 38: 392-400 Year: 2011 Interstitial lung diseases, mortality and associated risk factors Source: Eur Respir J 2004; 24: Suppl. 48, 667s Year: 2004 Venous thromboembolic disease in patients with small cell lung cancer: incidence and clinicopathological risk factors Source: Virtual Congress 2020 – Pulmonary embolism and beyond Year: 2020 Evaluation of cancer-associated thrombosis risk in patients with lung adenocarcinoma using the COMPASS-CAT risk assessment model Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021 Cumulative incidence and associated risk factor of chronic pulmonary infection after lung resection surgery for lung cancer Source: International Congress 2019 – Diagnosis of lung cancer Year: 2019